Where did I ever say it's worthless? You really need to get a grip on reality.
I said quite clearly that I believe the incumbents will likely retain the high volume initial scans and Cu64 will garner a substantial market in scans after initial diagnosis and recurrence monitoring.
Additionally I said it will take the part of the market where only the older machines are available.
Looking ahead a few years I'm betting those newer scanners will be everywhere, both lafov and improved safov machines.
That's my opinion and my holding ratios of certain stocks reflect that view.
We'll see who makes the most money in the end i suppose.
CU6 Price at posting:
$2.29 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)